Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain
- First Posted Date
- 2007-10-25
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 459
- Registration Number
- NCT00549042
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
- First Posted Date
- 2007-09-19
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Registration Number
- NCT00531856
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Universtiy of CA, San Francisco, San Francisco, California, United States
Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 75
- Registration Number
- NCT00493246
- Locations
- 🇺🇸
CS Mott Childrens Hospital, Ann Arbor, Michigan, United States
🇺🇸Lucile Packard Children's Hospital, Stanford, California, United States
🇺🇸Duke University Health Systems, Durham, North Carolina, United States
Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males
- Conditions
- Fever
- Interventions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 60
- Registration Number
- NCT00493311
- Locations
- 🇺🇸
Scirex Research Center, Austin, Texas, United States
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
- Conditions
- Postoperative PainHysterectomy
- Interventions
- Drug: IV Placebo 100 mL solution
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 331
- Registration Number
- NCT00399568
- Locations
- 🇺🇸
Stony Brook Anesthesiology Health Sciences Cente, Stony Brook, New York, United States
🇺🇸Allegheny Pain Managment, Altoona, Pennsylvania, United States
🇺🇸Weill Medical College, New York, New York, United States
Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
- Conditions
- Acute Graft-versus-Host Disease
- Interventions
- Procedure: Ecp
- First Posted Date
- 2006-01-26
- Last Posted Date
- 2017-08-16
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 19
- Registration Number
- NCT00282503
- Locations
- 🇩🇪
University of Rostock, Rostock, Germany
🇧🇪University Hospital Gasthuisberg, Leuven, Belgium
🇧🇪Centre Hopitalier Universitaire Sart Tilman Liege, Liege, Belgium
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
- Conditions
- Crohn's Disease
- Interventions
- Procedure: Extracorporeal Photopheresis
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 25
- Registration Number
- NCT00221026
- Locations
- 🇺🇸
Morristown Memorial Hospital, Morristown, New Jersey, United States
🇧🇪Hospital Erasme/ULB, Brussels, Belgium
🇩🇪Universitat St Josef, Bochum, Germany
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 86
- Registration Number
- NCT00221000
- Locations
- 🇺🇸
Clinical Pharmacology Study Group, Worchester, Massachusetts, United States
🇮🇹Universita de Genova - Ospedale S. Martino, Genova, Italy
🇺🇸Carolina Arthritis Associates, Wilmington, North Carolina, United States
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
- First Posted Date
- 2004-10-28
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 150
- Registration Number
- NCT00094887
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Colorado Sickle Cell Treatement and Research Center, Aurora, Colorado, United States
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
- First Posted Date
- 2004-08-09
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 112
- Registration Number
- NCT00089570
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸University of Medicine & Dentistry of New Jersey - NJMS, Newark, New Jersey, United States
🇺🇸Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States